Al Hammadi extends agreement to acquire 35% of Sudair Pharmaceutical for 1 month

10/10/2021 Argaam

Logo of Al Hammadi Company for Development and Investment

Al Hammadi Company for Development and Investment extended the duration of the agreement to acquire 35% of Sudair Pharmaceutical Co. (SPC) for one month, the company said in a filing to Tadawul.

 

The move does not have any financial impact.

 

In July, Al Hammadi signed an agreement to acquire Gulf Investment Corporation’s (GIC) 35% stake in SPC, Argaam earlier reported.

 

 

For More M&As 

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.